4.6 Article

β-Adrenergic Receptor Desensitization/Down-Regulation in Heart Failure: A Friend or Foe?

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2022.925692

关键词

beta-adrenergic receptor; beta-adrenergic receptor desensitization/down-regulation; cardiac ryanodine receptor; calcium leak; arrhythmia; heart failure

向作者/读者索取更多资源

Cardiac sympathetic activation and abnormal Ca2+ handling are important factors in the progression of heart failure. The interaction between beta-adrenergic receptor desensitization/down-regulation and abnormal Ca2+ handling in heart failure leads to cardiac dysfunction and arrhythmias.
Cardiac sympathetic activation, mediated by beta-adrenergic receptors (beta-ARs), normally increases cardiac contraction and relaxation. Accomplishing this task requires a physiological, concerted Ca2+ signaling, being able to increase Ca2+ release from sarcoplasmic reticulum (SR) in systole and speed up Ca2+ re-uptake in diastole. In heart failure (HF) myocardial beta-ARs undergo desensitization/down-regulation due to sustained sympathetic adrenergic activation. beta-AR desensitization/down-regulation diminishes adrenergic signaling and cardiac contractile reserve, and is conventionally considered to be detrimental in HF progression. Abnormal Ca2+ handling, manifested as cardiac ryanodine receptor (RyR2) dysfunction and diastolic Ca2+ leak (due to sustained adrenergic activation) also occur in HF. RyR2 dysfunction and Ca2+ leak deplete SR Ca2+ store, diminish Ca2+ release in systole and elevate Ca2+ levels in diastole, impairing both systolic and diastolic ventricular function. Moreover, elevated Ca2+ levels in diastole promote triggered activity and arrhythmogenesis. In the presence of RyR2 dysfunction and Ca2+ leak, further activation of the beta-AR signaling in HF would worsen the existing abnormal Ca2+ handling, exacerbating not only cardiac dysfunction, but also ventricular arrhythmogenesis and sudden cardiac death. Thus, we conclude that beta-AR desensitization/down-regulation may be a self-preserving, adaptive process (acting like an intrinsic beta-AR blocker) protecting the failing heart from developing lethal ventricular arrhythmias under conditions of elevated sympathetic drive and catecholamine levels in HF, rather than a conventionally considered detrimental process. This also implies that medications simply enhancing beta-AR signaling (like beta-AR agonists) may not be so beneficial unless they can also correct dysfunctional Ca2+ handling in HF.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据